Ilorasertib Uses, Dosage, Side Effects and more
Ilorasertib has been used in trials studying the treatment of Myelodysplasia, Solid Neoplasm, Advanced Cancers, Advanced Solid Tumors, and Acute Myelogenous Leukemia, among others.
| Trade Name | Ilorasertib |
| Generic | Ilorasertib |
| Ilorasertib Other Names | Ilorasertib |
| Type | |
| Formula | C25H21FN6O2S |
| Weight | Average: 488.54 Monoisotopic: 488.143073277 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
